Warrant classification under ASC 815-40 and IAS 32: liability or equity

A warrant issued by a company on its own shares is classified as equity under US GAAP only if it passes three filters in sequence: it must fall outside ASC 480, it must be indexed to the issuer's own stock under ASC 815-40, and it must meet the equity classification conditions of the same Subtopic. Under IFRS, IAS 32 applies one central test: a derivative on own shares is equity only when the issuer exchanges a fixed amount of cash for a fixed number of its own equity instruments. A warrant that fails these tests is a derivative liability measured at fair value, with every change in the share price flowing through profit or loss.

The two frameworks reach the same answer for a plain warrant with a fixed exercise price in the issuer's functional currency, a fixed number of shares and physical settlement. They diverge on the details that appear in real warrant agreements: net cash settlement options, anti-dilution resets, exercise prices in a foreign currency, tender offer clauses and settlement choices held by the holder. Those details decide whether a company reports a stable equity balance or a liability that produces gains when its share price falls and losses when it rises.

The worked example below follows a $20,000,000 unit offering with 1,000,000 warrants through issuance, a period-end remeasurement and exercise, first as a liability and then as equity. In the liability case the company records a cumulative loss of $1,500,000 in earnings before the warrants are exercised, while the equity-classified version of the same transaction never touches the income statement.

··········

WHEN WARRANT CLASSIFICATION ARISES IN PRACTICE.

Warrants appear in several common financings. Growth companies issue units of one share plus a fraction of a warrant in public and private placements; lenders receive warrants as a sweetener on term loans and venture debt; special purpose acquisition companies issue public and private placement warrants; and investors in PIPE transactions often negotiate warrant coverage. In each case the issuer must decide on day one whether the warrant is a liability, an asset in rare cases, or an equity instrument, and it must reassess the classification at each reporting date under US GAAP.

The question became highly visible in April 2021, when the SEC's Office of the Chief Accountant published a staff statement on warrants issued by special purpose acquisition companies. Many of those warrants had been reported as equity, and the statement pointed to provisions that caused them to fail the indexation guidance or the equity classification conditions of ASC 815-40. A large number of issuers restated their financial statements to report the warrants as liabilities at fair value. The terms that triggered those restatements, such as settlement amounts that depend on who holds the warrant and cash payments in a tender offer not available to all shareholders, still appear in warrant agreements today.

Classification affects more than the balance sheet line. A liability-classified warrant is remeasured at fair value through earnings every period, which can create large non-operating gains and losses, affects debt covenants that refer to liabilities or net income, and changes the diluted earnings per share calculation. An equity-classified warrant is measured once at issuance and stays in equity until it is exercised or lapses.

··········

HOW ASC 480 AND ASC 815-40 CLASSIFY WARRANTS UNDER US GAAP.

The US GAAP analysis starts with ASC 480 Distinguishing Liabilities from Equity. A freestanding warrant on shares that are puttable by the holder or mandatorily redeemable is a liability under ASC 480, because the issuer may have to transfer cash or other assets to settle the obligation embedded in the underlying shares. Warrants issued by a company whose preferred shares are redeemable at the holder's option are the usual example. When ASC 480 applies, the analysis ends there and the warrant is a liability measured at fair value.

If ASC 480 does not apply, the issuer moves to ASC 815-40 Contracts in Entity's Own Equity. The first step is indexation. A warrant is indexed to the issuer's own stock when any contingent exercise provision is not based on an observable market or index unrelated to the issuer's own stock or operations, and when the settlement amount equals the difference between the fair value of a fixed number of shares and a fixed exercise price. Adjustments to the exercise price or the number of shares do not break indexation when the only variables that can change the settlement amount are inputs to the fair value of a fixed-for-fixed option, such as the share price, volatility, dividends and the term. An adjustment that depends on the characteristics of the holder, or on an index unrelated to the issuer, causes the warrant to fail. An exercise price denominated in a currency other than the issuer's functional currency also means the warrant is not considered indexed to the issuer's own stock under US GAAP.

The second step applies the equity classification conditions of ASC 815-40. The overriding principle is that a contract which could require net cash settlement on an event outside the issuer's control is classified as an asset or liability. The guidance allows an exception when the holders of the underlying shares would also receive cash in the same event, which is why change-of-control clauses that pay all shareholders the same form of consideration usually do not prevent equity classification. ASU 2020-06 simplified the remaining conditions by removing the requirements to consider settlement in unregistered shares, collateral and shareholder rights, and it clarified that penalty payments for failing to file on time do not preclude equity classification. The remaining conditions address whether the issuer has sufficient authorized and unissued shares, whether the contract caps the number of shares to be delivered, and whether the contract contains cash-settled top-off or make-whole provisions. ASU 2020-06 became effective for SEC filers that are public business entities, excluding entities eligible to be smaller reporting companies, for fiscal years beginning after December 15, 2021, and for all other entities for fiscal years beginning after December 15, 2023.

A warrant that fails either step is recorded as a liability, or occasionally an asset, at fair value with changes reported in earnings. Classification is reassessed at each balance sheet date, so a warrant can move between liability and equity when facts change, for example when the issuer increases its authorized shares. Reclassification takes place at the fair value on the date of the change, and gains or losses recognized while the warrant was a liability are not reversed.

··········

THE IAS 32 FIXED-FOR-FIXED TEST FOR WARRANTS.

IAS 32 Financial Instruments: Presentation defines a financial liability to include a derivative that will or may be settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity's own equity instruments (paragraph 11). Paragraph 16 mirrors that rule on the equity side: a derivative is an equity instrument only if it will be settled solely by the issuer exchanging a fixed amount of cash for a fixed number of its own equity instruments. This fixed-for-fixed condition is the core of the IFRS analysis for warrants.

The test is applied strictly. A warrant whose exercise price resets when the company issues shares at a lower price, a warrant settled net in cash, or a warrant whose number of shares varies with a formula other than the fixed-for-fixed exchange is a derivative financial liability. When the holder or the issuer can choose between settlement methods, such as net cash, net shares or gross physical delivery, the warrant is a financial liability unless every settlement alternative would result in equity classification. Cashless exercise features therefore need careful reading: a net share settlement option alongside gross physical settlement fails fixed-for-fixed under IAS 32 even though it may be acceptable under US GAAP.

Currency is a frequent source of difference. A fixed exercise price in a currency other than the issuer's functional currency is not a fixed amount of cash for IAS 32 purposes, so the warrant is a liability. The standard contains one exception in the definition of a financial liability: rights, options or warrants to acquire a fixed number of the entity's own equity instruments for a fixed amount of any currency are equity instruments if the entity offers them pro rata to all of its existing owners of the same class of non-derivative equity instruments. That exception covers rights issues and does not extend to warrants issued to a subset of investors, lenders or placement agents.

A warrant classified as a financial liability is measured at fair value through profit or loss under IFRS 9. An equity-classified warrant is recognized in equity at the amount received for it and is not remeasured. The IFRS Interpretations Committee has considered whether a warrant classified as a liability because its exercise price was variable should be reclassified to equity once the exercise price becomes fixed after initial recognition. The Committee observed that IAS 32 contains no general requirements for reclassifying financial liabilities and equity instruments after initial recognition when the contractual terms are unchanged, and referred the issue to the IASB's Financial Instruments with Characteristics of Equity project. Companies therefore apply an accounting policy to that fact pattern until the Board completes its work.

··········

WARRANT CLASSIFICATION: ASC 815-40 VS IAS 32.

........

Feature	US GAAP (ASC 480, ASC 815-40)	IFRS (IAS 32, IFRS 9)
Core test	ASC 480 scope, then indexation and equity conditions	Fixed amount of cash for fixed number of shares
Warrant on puttable or redeemable shares	Liability under ASC 480	Usually liability; depends on the underlying instrument
Price adjustments based on fair value inputs	Can still be indexed	Generally fail fixed-for-fixed
Net share settlement at issuer's choice	Can be equity	Liability unless all settlement options give equity
Exercise price in a foreign currency	Not indexed, liability	Liability, except pro rata rights issues
Cash on events outside issuer control	Liability unless all shareholders also receive cash	Liability if the issuer cannot avoid paying cash
Liability measurement	Fair value through earnings	Fair value through profit or loss
Reassessment	Each reporting date	No general reclassification rule if terms unchanged

........

The table shows why the same warrant agreement can be equity under US GAAP and a liability under IFRS. The US indexation guidance accepts adjustments that keep the warrant's value tied to a fixed-for-fixed option, while IAS 32 treats almost any variability in the cash or the number of shares as a failure. Groups that report under both frameworks, or US subsidiaries of IFRS parents, should expect differences on down round protection, net share settlement and currency.

··········

WORKED EXAMPLE: LIABILITY-CLASSIFIED WARRANTS IN A UNIT OFFERING.

The following figures are illustrative. A company with a US dollar functional currency issues 2,000,000 units at $10.00 each, raising $20,000,000. Each unit contains one common share with a par value of $0.001 and one half of a warrant, so the offering includes 1,000,000 warrants, each exercisable for one share at $10.00 for five years. The warrant agreement contains a provision that fails the ASC 815-40 indexation guidance, and the same provision fails fixed-for-fixed under IAS 32, so the warrants are liabilities under both frameworks. The fair value of one warrant is $1.50 at issuance, $2.10 at the first reporting date and $3.00 on the date all warrants are exercised. Offering costs are $1,200,000.

Because the warrants are remeasured at fair value, the proceeds are allocated to them first at their full fair value of $1,500,000, and the residual of $18,500,000 is allocated to the shares. Offering costs are allocated in proportion to the proceeds: $90,000 relates to the warrant liability and is expensed immediately, and $1,110,000 relates to the shares and is charged to additional paid-in capital.

........

Entry	Account	Debit ($)	Credit ($)
1. Issuance	Cash	20,000,000
	Warrant liability		1,500,000
	Common stock (2,000,000 x $0.001)		2,000
	Additional paid-in capital		18,498,000
2. Offering costs	Transaction cost expense (warrants)	90,000
	Additional paid-in capital	1,110,000
	Cash		1,200,000
3. Period-end remeasurement	Loss on change in fair value of warrants	600,000
	Warrant liability		600,000
4. Remeasurement at exercise	Loss on change in fair value of warrants	900,000
	Warrant liability		900,000
5. Exercise	Cash (1,000,000 x $10.00)	10,000,000
	Warrant liability	3,000,000
	Common stock (1,000,000 x $0.001)		1,000
	Additional paid-in capital		12,999,000

........

Each entry balances. The warrant liability rises from $1,500,000 to $2,100,000 at the reporting date and to $3,000,000 at exercise, so the company reports cumulative losses of $1,500,000 in earnings, plus the $90,000 of offering costs expensed. On exercise, the liability is remeasured to fair value and then transferred into equity together with the $10,000,000 of cash received. Under IFRS the entries are the same in substance, with share capital and share premium replacing common stock and additional paid-in capital, and the remeasurement losses presented in finance costs or another line chosen under the entity's presentation policy.

··········

EQUITY-CLASSIFIED WARRANTS: THE SAME OFFERING WITHOUT REMEASUREMENT.

Assume instead that the warrant agreement contains no problematic provision, so the warrants pass ASC 815-40 and the fixed-for-fixed test. Both the shares and the warrants are equity, and the allocation of the $20,000,000 between them is a split within equity with no effect on earnings. One common approach is a relative fair value allocation: with shares worth $20,000,000 and warrants worth $1,500,000, the warrants receive $1,395,348.84 and the shares $18,604,651.16. All $1,200,000 of offering costs are charged to equity.

........

Entry	Account	Debit ($)	Credit ($)
1. Issuance	Cash	20,000,000.00
	Common stock (2,000,000 x $0.001)		2,000.00
	Additional paid-in capital, shares		18,602,651.16
	Additional paid-in capital, warrants		1,395,348.84
2. Offering costs	Additional paid-in capital, shares	1,200,000.00
	Cash		1,200,000.00
3. Exercise	Cash (1,000,000 x $10.00)	10,000,000.00
	Additional paid-in capital, warrants	1,395,348.84
	Common stock (1,000,000 x $0.001)		1,000.00
	Additional paid-in capital, shares		11,394,348.84

........

No entry is recorded at the reporting date, even though the warrant's fair value has risen to $2.10, because equity instruments are not remeasured. Total equity after exercise is $28,800,000 in both versions of the example: $20,000,000 plus $10,000,000 of cash raised, less $1,200,000 of costs. The liability version reaches the same total equity with $1,590,000 of losses in retained earnings and a correspondingly higher additional paid-in capital, and that difference reaches earnings-based covenants and the net income figures investors track. If equity-classified warrants lapse unexercised, the amount stays in equity, and no gain is recognized under either framework.

··········

PRESENTATION, EPS AND DISCLOSURE FOR WARRANTS.

Liability-classified warrants are presented as a separate liability or within derivative liabilities, split between current and non-current under each framework's classification rules. Fair value changes are typically shown as a separate non-operating line, because large swings tied to the share price can otherwise distort operating results. Companies usually measure the warrants with an option pricing model, or with the quoted price where public warrants trade, and provide the fair value hierarchy disclosures required by ASC 820 or IFRS 13, including the significant unobservable inputs such as volatility for Level 3 measurements.

Warrants affect diluted earnings per share whichever way they are classified. Under US GAAP the treasury stock method generally applies to warrants, and for liability-classified warrants the issuer also considers removing the fair value gain or loss from the numerator when the warrants are dilutive. The mechanics are covered in our article on how earnings per share is calculated in complex capital structures. Under IAS 33, warrants are dilutive only when the average market price exceeds the exercise price.

Disclosure should describe the key terms of outstanding warrants, the number of shares issuable, the exercise price and expiry, the classification conclusion and, for liabilities, the valuation technique and inputs. Where warrants were issued with debt, the allocation of proceeds also creates a debt discount, a topic covered in our analysis of convertible debt and embedded derivatives under IFRS 9, IAS 32, ASC 470-20 and ASC 815.

··········

COMMON ERRORS IN WARRANT CLASSIFICATION.

The most frequent error is reading only the headline terms of the warrant. Indexation and settlement failures sit in the adjustment, tender offer, fundamental transaction and settlement mechanics sections of the agreement, and a single clause that changes the settlement amount based on who holds the warrant is enough to require liability classification under ASC 815-40.

A second error is applying the US GAAP conclusion to IFRS reporting, or the reverse. Down round protection, net share settlement options and foreign currency exercise prices are the usual points of divergence, and group reporting packages for subsidiaries need a separate analysis for each framework. The wider debt and equity analysis, including instruments with contingent settlement provisions, is covered in our article on how hybrid financial instruments are classified between debt and equity under IAS 32 and ASC 480.

Other common mistakes include allocating unit proceeds by relative fair value when the warrants are liabilities, which understates the liability; capitalizing transaction costs that relate to a liability measured at fair value through earnings; forgetting to reassess US GAAP classification when authorized shares run low; and failing to remeasure the warrant liability immediately before exercise, which leaves the loss in the wrong period.

··········

WARRANT CLASSIFICATION CHECKLIST FOR CONTROLLERS.

1. Confirm whether the warrant is freestanding or embedded in another instrument, and whether the underlying shares are puttable or redeemable.

2. Under US GAAP, test ASC 480 scope, then indexation under ASC 815-40, then the equity classification conditions, documenting each clause reviewed.

3. Under IFRS, test fixed-for-fixed under IAS 32, including every settlement option available to the holder or the issuer and the currency of the exercise price.

4. Check authorized and unissued shares against all instruments that may require share delivery.

5. For liabilities, select a valuation method and inputs, allocate proceeds and costs accordingly, and plan the remeasurement at each reporting date and immediately before exercise.

6. Reflect the warrants in diluted earnings per share and prepare the fair value and terms disclosures.

··········

LIABILITY OR EQUITY WARRANTS: JUDGEMENT AREAS UNDER ASC 815-40 AND IAS 32.

A plain warrant with a fixed exercise price in the functional currency, a fixed number of shares, physical settlement and no cash obligations outside the issuer's control is equity under both ASC 815-40 and IAS 32. Warrants on redeemable shares, warrants settled net in cash and warrants with exercise prices in a foreign currency are liabilities under both, subject to the IFRS exception for pro rata rights issues. Liability-classified warrants are measured at fair value with changes in earnings, and the difference reaches the income statement every quarter.

Judgement remains in the reading of adjustment and settlement clauses, where US GAAP accepts adjustments based on fair value inputs and IAS 32 usually does not; in the treatment of change-of-control and tender offer provisions; in the IFRS policy for warrants whose terms become fixed after issuance, pending the IASB's work on financial instruments with characteristics of equity; and in valuation inputs such as volatility for private companies. Companies that draft warrant agreements with the accounting tests in mind before signing avoid most of the restatement risk.

··········

FOLLOW US FOR MORE.

·····

DATA STUDIOS

·····

datastudios.org